| A Study of Donanemab (LY3002813) in Healthy Participants (NCT05567159) | Eli Lilly and Company | 2022-10-04 |
| A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole (NCT05551897) | AstraZeneca | 2022-10-04 |
| A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy (NCT05435339) | Genmab | 2022-10-04 |
| Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study) (NCT05567757) | Vascudyne, Inc. | 2022-10-04 |
| A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer (NCT05543629) | Bristol-Myers Squibb | 2022-10-04 |
| A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies (NCT05453903) | Janssen Research & Development, LLC | 2022-10-04 |
| Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare (NCT05580042) | TWi Biotechnology, Inc. | 2022-10-03 |
| Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) (NCT04086485) | National Cancer Institute (NCI) | 2022-10-03 |
| Psilocybin-assisted Therapy for Phantom Limb Pain (NCT05224336) | University of California, San Diego | 2022-10-03 |
| Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device (NCT06254664) | Xiromed LLC | 2022-10-03 |
| Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (NCT05581407) | LiteVax BV | 2022-10-03 |
| Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg (NCT06719986) | Purdue Pharma LP | 2022-10-03 |
| A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa (NCT05453578) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-10-03 |
| Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma (NCT04922723) | West Virginia University | 2022-10-03 |
| Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies (NCT05397496) | Novartis Pharmaceuticals | 2022-10-03 |
| CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies (NCT04892277) | Mayo Clinic | 2022-10-03 |
| First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy Participants (NCT05393271) | ViiV Healthcare | 2022-10-03 |
| Study of WPV01 in Healthy Subjects (NCT06205329) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2022-10-03 |
| Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors (NCT05429762) | Sanofi | 2022-10-03 |
| Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers (NCT05586542) | Vitruvian Medical Devices, Inc. | 2022-10-03 |
| Vascular Endothelial Dysfunction in Sleep Apnea (NCT05289063) | Columbia University | 2022-10-03 |
| Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older (NCT05553301) | Sanofi Pasteur, a Sanofi Company | 2022-10-03 |
| Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors (NCT05511844) | Orum Therapeutics USA, Inc. | 2022-10-03 |
| Effectiveness of PRP, Conditioned Medium UC-MSCs Secretome and Hyaluronic Acid for the Treatment of Knee Osteoarthritis (NCT05579665) | Universitas Sriwijaya | 2022-10-02 |
| Home-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson's Disease (NCT06840678) | Fundación de investigación HM | 2022-10-01 |
| Mirtazapine for Chronic Insomnia in Older Adults (NCT05247697) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-10-01 |
| Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study (NCT05586841) | Beijing 302 Hospital | 2022-10-01 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets (NCT05668897) | Fujian Akeylink Biotechnology Co., Ltd. | 2022-10-01 |
| Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma (NCT05536427) | Peking Union Medical College Hospital | 2022-10-01 |
| Breast Stimulation vs. Low Dose Oxytocin Augmentation for Labor Induction (NCT05510310) | Western Galilee Hospital-Nahariya | 2022-10-01 |
| The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects (NCT05607589) | Daewoong Pharmaceutical Co. LTD. | 2022-10-01 |
| Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors (NCT05469490) | Luke, Jason, MD | 2022-10-01 |
| Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain (NCT05561023) | Fujian Cancer Hospital | 2022-10-01 |
| Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers (NCT05430958) | Inovio Pharmaceuticals | 2022-10-01 |
| A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (NCT05489679) | Accutar Biotechnology Inc | 2022-10-01 |
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer (NCT05575804) | Fudan University | 2022-10-01 |
| Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block (NCT05559437) | Egymedicalpedia | 2022-10-01 |
| Study of SM-88 in Advanced Cancers (NCT02562612) | Tyme, Inc | 2022-10-01 |
| Acute Effects of R- and S-MDMA in Healthy Subjects (NCT05277636) | University Hospital, Basel, Switzerland | 2022-10-01 |
| The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients (NCT04731051) | King Hussein Cancer Center | 2022-10-01 |
| Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma (NCT05007418) | Sorrento Therapeutics, Inc. | 2022-10-01 |
| A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis (NCT05525715) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2022-10-01 |
| Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies (NCT05570188) | Kunming Hope of Health Hospital | 2022-10-01 |
| Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer (NCT05503888) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-10-01 |
| Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships (NCT05912842) | Temple University | 2022-10-01 |
| Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome (NCT06199544) | Hamdard University | 2022-10-01 |
| A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects (NCT05549531) | Idorsia Pharmaceuticals Ltd. | 2022-10-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug (NCT05234320) | Caregen Co. Ltd. | 2022-10-01 |
| A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors (NCT05508620) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-10-01 |
| Fucoidan Assisted Eradication of Helicobacter Pylori (NCT05461508) | Nanjing First Hospital, Nanjing Medical University | 2022-10-01 |
| Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL (NCT05554575) | Bioceltech Therapeutics, Ltd. | 2022-10-01 |
| Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients (NCT05559242) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-10-01 |
| Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies (NCT05487651) | Athenex, Inc. | 2022-10-01 |
| Bacteriophage Therapy in Patients With Prosthetic Joint Infections (NCT04787250) | Adaptive Phage Therapeutics, Inc. | 2022-10-01 |
| A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05527275) | Sun Yat-sen University | 2022-10-01 |
| Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 (NCT04490486) | Joshua M Hare | 2022-10-01 |
| Effects of Peripheral Magnetic Stimulation on Cortical Excitability in Healthy Individuals (NCT07025759) | Universidade Federal de Pernambuco | 2022-10-01 |
| The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear (NCT05497934) | Nova Scotia Health Authority | 2022-10-01 |
| The Effect of Melatonin on Postoperative Pain Reduction After Orthognathic Surgery (NCT03995004) | The University of Hong Kong | 2022-10-01 |
| Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients (NCT06202001) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-10-01 |
| Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis (NCT05477446) | Beijing Friendship Hospital | 2022-10-01 |
| Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 (NCT05620472) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2022-10-01 |
| Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM (NCT05408026) | Alliance Foundation Trials, LLC. | 2022-10-01 |
| Azacytidine During Anti-tuberculosis Therapy (NCT03941496) | Andrew Dinardo | 2022-10-01 |
| SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc Expression (NCT05498636) | The Affiliated Hospital of Qingdao University | 2022-10-01 |
| Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM (NCT05760677) | Affiliated Hospital of Nantong University | 2022-10-01 |
| A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group. (NCT06620614) | National Academy of Medical Sciences, Nepal | 2022-10-01 |
| 6MW3511 in Patients With Advanced Solid Tumor (NCT05524194) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-10-01 |
| Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (NCT05571540) | Kunming Hope of Health Hospital | 2022-10-01 |
| Effects of Trans-spinal Magnetic Stimulation on Cortical Excitability in Healthy Individuals (NCT07026760) | Universidade Federal de Pernambuco | 2022-10-01 |
| Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors (NCT05461287) | Qilu Pharmaceutical Co., Ltd. | 2022-09-30 |
| Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus (NCT05048238) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-30 |
| A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012) (NCT06655311) | Merck Sharp & Dohme LLC | 2022-09-30 |
| Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers (NCT05814809) | Onconic Therapeutics Inc. | 2022-09-30 |
| Onvansertib + Paclitaxel In TNBC (NCT05383196) | Antonio Giordano, MD | 2022-09-30 |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies (NCT05443126) | Ellipses Pharma | 2022-09-30 |
| A Umbrella Study in R/R PTCL Guided by Molecular Subtypes (NCT05559008) | Ruijin Hospital | 2022-09-30 |
| TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps (NCT04998305) | Hiroshi Mitsumoto | 2022-09-30 |
| A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma (NCT05569057) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-09-30 |
| A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer (NCT05566574) | Memorial Sloan Kettering Cancer Center | 2022-09-30 |
| Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks (NCT05597462) | Journey Medical Corporation | 2022-09-30 |
| Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects (NCT05310487) | Yangshengtang Co., Ltd | 2022-09-30 |
| A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05581693) | Celltrion | 2022-09-30 |
| A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC (NCT05543330) | Wuhan YZY Biopharma Co., Ltd. | 2022-09-30 |
| Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men (NCT04922424) | Yale University | 2022-09-30 |
| A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors (NCT04614766) | David Bushnell | 2022-09-30 |
| A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors (NCT05499715) | Chinese Academy of Medical Sciences | 2022-09-30 |
| T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors (NCT05200559) | Alexander B Olawaiye, MD | 2022-09-30 |
| Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas (NCT05415098) | Ascentage Pharma Group Inc. | 2022-09-30 |
| Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D (NCT05480657) | Eledon Pharmaceuticals | 2022-09-30 |
| Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia (NCT05505539) | University of California, San Francisco | 2022-09-30 |
| Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma (NCT05539118) | Xijing Hospital | 2022-09-30 |
| Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma (NCT04635683) | Yazeed Sawalha | 2022-09-30 |
| EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (NCT05521412) | Peter MacCallum Cancer Centre, Australia | 2022-09-29 |
| A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food (NCT05520827) | Boehringer Ingelheim | 2022-09-29 |
| A Study of EDP-323 in Healthy Subjects (NCT05587478) | Enanta Pharmaceuticals, Inc | 2022-09-29 |
| Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 (NCT05549401) | Chong Kun Dang Pharmaceutical | 2022-09-29 |
| Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT05319587) | Moleculin Biotech, Inc. | 2022-09-29 |
| Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122 (NCT04634513) | University of Maryland, Baltimore | 2022-09-29 |
| Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B (NCT05618730) | Eximore Ltd. | 2022-09-29 |